NeoGenomics (NEO)
(Delayed Data from NSDQ)
$15.80 USD
-0.48 (-2.95%)
Updated Sep 23, 2024 03:59 PM ET
After-Market: $15.80 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Income Statements
Fiscal Year end for NeoGenomics, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 592 | 510 | 484 | 444 | 409 |
Cost Of Goods | 347 | 322 | 297 | 259 | 212 |
Gross Profit | 245 | 188 | 187 | 186 | 197 |
Selling & Adminstrative & Depr. & Amort Expenses | 352 | 346 | 306 | 200 | 184 |
Income After Depreciation & Amortization | -108 | -158 | -119 | -14 | 13 |
Non-Operating Income | 18 | 0 | 109 | 7 | -6 |
Interest Expense | 7 | 2 | 5 | 7 | 4 |
Pretax Income | -97 | -159 | -15 | -14 | 4 |
Income Taxes | -9 | -15 | -7 | -18 | -4 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -88 | -144 | -8 | 4 | 8 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -88 | -144 | -8 | 4 | 8 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -32 | -85 | -63 | 26 | 44 |
Depreciation & Amortization (Cash Flow) | 75 | 72 | 56 | 40 | 31 |
Income After Depreciation & Amortization | -108 | -158 | -119 | -14 | 13 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 125.50 | 124.22 | 119.96 | 111.79 | 103.62 |
Diluted EPS Before Non-Recurring Items | -0.31 | -0.76 | -0.27 | 0.07 | 0.23 |
Diluted Net EPS (GAAP) | -0.70 | -1.16 | -0.07 | 0.04 | 0.08 |
Fiscal Year end for NeoGenomics, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 164.50 | 156.24 | 155.55 | 151.95 | 146.92 |
Cost Of Goods | 92.01 | 90.77 | 87.96 | 89.64 | 87.03 |
Gross Profit | 72.49 | 65.47 | 67.59 | 62.31 | 59.89 |
SG&A, R&D, and Dept/Amort Expenses | 94.44 | 96.04 | 86.16 | 86.51 | 89.78 |
Income After SG&A, R&D, and Dept/Amort Expenses | -21.95 | -30.57 | -18.57 | -24.20 | -29.89 |
Non-Operating Income | 4.59 | 4.57 | 0.12 | -0.10 | 0.73 |
Interest Expense | 1.67 | 1.69 | 13.74 | -2.84 | -2.52 |
Pretax Income | -19.02 | -27.68 | -15.29 | -21.45 | -26.64 |
Income Taxes | -0.38 | -0.62 | -0.96 | -2.94 | -2.31 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -18.64 | -27.06 | -14.33 | -18.52 | -24.33 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -18.64 | -27.06 | -14.33 | -18.52 | -24.33 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 126.41 | 126.11 | 125.93 | 125.69 | 125.36 |
Diluted EPS Before Non-Recurring Items | -0.04 | -0.08 | -0.02 | -0.06 | -0.09 |
Diluted Net EPS (GAAP) | -0.15 | -0.21 | -0.11 | -0.15 | -0.19 |